about
Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)Quantification of risk factors for herpes zoster: population based case-control studyRepresentativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)Statin use and the risk of herpes zoster: a nested case-control study using primary care data from the U.K. Clinical Research Practice DatalinkBody-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adultsRisky driving among UK regular armed forces personnel: changes over timeThe impact of the conflicts of Iraq and Afghanistan: a UK perspective.Irritable bowel syndrome in the UK military after deployment to Iraq: what are the risk factors?Inequalities in zoster disease burden: a population-based cohort study to identify social determinants using linked data from the UK Clinical Practice Research Datalink.Varicella and herpes zoster vaccine development: lessons learned.Early Service leavers: a study of the factors associated with premature separation from the UK Armed Forces and the mental health of those that leave early.Effectiveness of herpes zoster vaccination in an older United Kingdom population.Viral load and antibody boosting following herpes zoster diagnosis.Association of herpesviruses and stroke: Systematic review and meta-analysisZoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research DatalinkRisk factors for herpes simplex virus type-1 infection and reactivation: Cross-sectional studies among EPIC-Norfolk participantsSevere and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort studyRisk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data
P50
Q28654992-E84DC42B-2724-43F3-8B51-8F23DB6D0F3EQ28657403-CDF2281D-7D17-4B99-914B-F981EDC0AE3DQ28680747-0B73A769-7397-412F-A52C-7A156833ABB2Q31107524-7BA556DC-1F30-4901-AF15-A55064852AB7Q34041755-52EA9BEF-822E-41C4-9936-46D8F76AC9B9Q36120497-832D718F-AD81-40AF-B552-3376A4783FC7Q37869131-25260C0C-96B6-4F1D-B501-7C65752E20ABQ43516772-D8135573-6E0C-45D6-BC98-09F98F4649BDQ47547508-A09EE241-F8AD-475B-B4C0-A21E03948299Q47607699-0C1BDFFB-75CA-4475-9CBE-F60334DD85D7Q47843898-1EBB9BBA-EAAD-4511-A6F3-84C306C34275Q52648252-B409D79D-9AD1-424A-A6A0-637BC25D9417Q55325101-28925D00-7524-43D6-8F6F-4BDCE03A0364Q59350410-0CD0E914-D771-47EC-8D8A-01692037FCD9Q59804620-E2B64B64-6CB9-4303-860A-9575687EC3EFQ64060908-1E6B3D21-C82A-4049-AFCD-1B170A4F1092Q88787251-49D848CA-57DF-4EC2-A4A9-5A9EDA6CFF56Q92858366-50B8340D-A2D1-4875-BCDF-0B2224D571C6
P50
description
investigador
@es
researcher
@en
name
Harriet Forbes
@en
type
label
Harriet Forbes
@en
prefLabel
Harriet Forbes
@en
P31
P496
0000-0001-6888-2212